Adeno-associated virus (AAV)-based gene therapies offer life-changing potential for treating genetic diseases, yet high production costs remain a significant barrier. Optimizing these processes is ...
Although the targets of biomanufacturing have evolved from therapeutic proteins to “advanced therapies” and now to gene therapies, the issues and solutions remain the same. The production of safe, ...
Cell and gene therapies have brought great advances to the treatment of severe diseases previously deemed untreatable. Despite commercial and clinical success of AAV-based gene therapies (seven ...
Pharmaron Biologics, Liverpool, UK, is a commercial development and manufacturing organization (CDMO) that offers a range of unique end-to-end laboratory services for the development and manufacture ...
HOLLISTER, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (TKNO), a leading producer of critical reagents for the research, discovery, development ...
This session will highlight new research focused on optimizing AAV6 upstream production - an essential step in improving the safety and affordability of gene therapies. Using a design of experiment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results